HCA Healthcare, Inc. (NYSE:HCA) Shares Purchased by Epoch Investment Partners Inc.

Epoch Investment Partners Inc. increased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 16.4% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 631,854 shares of the company’s stock after acquiring an additional 88,948 shares during the period. HCA Healthcare makes up about 0.9% of Epoch Investment Partners Inc.’s investment portfolio, making the stock its 21st largest position. Epoch Investment Partners Inc. owned approximately 0.24% of HCA Healthcare worth $203,002,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of HCA. CreativeOne Wealth LLC acquired a new position in HCA Healthcare in the first quarter worth approximately $231,000. New Mexico Educational Retirement Board increased its stake in HCA Healthcare by 29.9% in the 1st quarter. New Mexico Educational Retirement Board now owns 13,900 shares of the company’s stock worth $4,636,000 after purchasing an additional 3,200 shares in the last quarter. Sanders Capital LLC boosted its holdings in shares of HCA Healthcare by 4.2% in the fourth quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock worth $3,086,836,000 after buying an additional 456,738 shares during the period. KBC Group NV grew its position in HCA Healthcare by 60.6% during the 4th quarter. KBC Group NV now owns 365,984 shares of the company’s stock worth $99,065,000 after purchasing an additional 138,146 shares in the last quarter. Finally, Kingswood Wealth Advisors LLC purchased a new position in shares of HCA Healthcare during the first quarter valued at $566,000. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Stock Performance

NYSE HCA opened at $404.66 on Friday. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. The company’s 50-day simple moving average is $370.57 and its 200 day simple moving average is $340.65. The stock has a market cap of $105.99 billion, a P/E ratio of 20.17, a PEG ratio of 1.46 and a beta of 1.67. HCA Healthcare, Inc. has a twelve month low of $215.96 and a twelve month high of $405.70.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, beating the consensus estimate of $4.97 by $0.53. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The business had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. During the same quarter in the previous year, the firm earned $4.29 EPS. HCA Healthcare’s quarterly revenue was up 10.3% on a year-over-year basis. As a group, research analysts forecast that HCA Healthcare, Inc. will post 22.46 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be paid a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.65%. The ex-dividend date is Monday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.16%.

Wall Street Analysts Forecast Growth

HCA has been the subject of a number of research analyst reports. Morgan Stanley began coverage on shares of HCA Healthcare in a research report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price target for the company. Leerink Partners boosted their target price on HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research note on Wednesday, July 24th. Truist Financial boosted their price target on HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, August 19th. Robert W. Baird began coverage on HCA Healthcare in a report on Thursday, May 30th. They issued an “outperform” rating and a $396.00 target price for the company. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $392.00 price objective on shares of HCA Healthcare in a research note on Monday, August 19th. Five analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and three have given a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $359.89.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, SVP Kathleen M. Whalen sold 2,987 shares of the firm’s stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total value of $1,085,804.37. Following the completion of the sale, the senior vice president now owns 9,454 shares of the company’s stock, valued at $3,436,623.54. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. The disclosure for this sale can be found here. Insiders have sold a total of 17,202 shares of company stock worth $6,407,273 in the last three months. Insiders own 1.60% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.